Sponsored

[podcast] Exploring the Benefits of Biotechnology with Abolis

P&F+ connects with Abolis CEO Cyrille Pauthenier to discuss the future of F&F utilizing biotechnology.
P&F+ connects with Abolis CEO Cyrille Pauthenier to discuss the future of F&F utilizing biotechnology.
This podcast is sponsored by: Abolis

With more and more F&F ingredients derived from fermentation and biotechnology being announced and penetrating the market with growing success, the F&F sector's attention is growing on this set of innovative tools and solutions to expand its ingredient offerings. Perfumer & Flavorist+ connects with Abolis CEO Cyrille Pauthenier to discuss the company's role in meeting the industry's needs in biotech, what it means to be “bio-synthesis architects” and more.

Abolis Biotechnologies is a European biotech company specializing in displacing unsustainable compounds and functionalities by developing new microbial strains and integrated bioprocesses, harnessing the power of natural biodiversity and microbial strain engineering. 

Register to listen!


More in Audio